Fri, May 6, 2022

Tejas Savant Maintained (ADPT) at Hold with Decreased Target to $18 on, May 6th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-18-on-may-6th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Tejas Savant of Morgan Stanley, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $27 to $18 on, May 6th, 2022.

Tejas has made no other calls on ADPT in the last 4 months.



There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, 0 agree with Tejas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Tejas


  • Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $30 on, Wednesday, February 16th, 2022